• No results found

Intracranial Dural Arteriovenous Fistulas: Classification, Imaging Findings, and Treatment

N/A
N/A
Protected

Academic year: 2020

Share "Intracranial Dural Arteriovenous Fistulas: Classification, Imaging Findings, and Treatment"

Copied!
7
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Table 2: Cognard classification of DAVFs13
Fig 2. Schematic overview of the Borden system of classifi-lesions are associated with cortical venous reflux
Fig 3. A 52-year-old man presented with severe headache, slurred speech, and acute left hemiparesis.DAVF (Borden type 3) with arterial supply from the bilateral middle meningeal and superficial temporal arteries
Fig 4. A 43-year-old woman with Factor V Leiden mutationproptosis and chemosis resolved the same day, and im-provement of left cranial nerve VI function was alreadyThe cavernous sinus was filled with coils (resulting in complete obliteration of the fistula
+2

References

Related documents

X-AREA ; data reduction: X-RED 32 (Stoe & Cie, 2002); program(s) used to solve structure: SHELXS 97 (Sheldrick, 1997); program(s) used to re®ne structure: SHELXL 97

Yet, as Levy (2005) contends, even if research and development and other creative functions are devolved to the offshore host locality, stakeholders in this region will

The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are

The publication of [1] had a great impact and captured the imagination of many. It encouraged others to identify data sets containing phenological data and brought forth

These distances are, on average, slightly shorter than the ReÐP bonds of the related mono- and dicarbene complexes which have -PPh 2 -bridging ligands instead (Haupt et al.. This is

Montelukast combined in asthma therapy, achieved better lung function and quality of life compared to Tiotropium and Theophyline in asthmatic

By In-vivo method: The efficacy of the sunscreen is usually expressed by Sun Protection Factor, which is defined as the UV energy required producing a minimal

Table 4: % Cumulative Olmesartan medoxomil released from ODTs containing varying concentrations of Croscarmellose sodium.. 1637 Table 6: % Cumulative Olmesartan medoxomil